A Study on Whether Patients Prefer the Spiriva® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:October 13, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:October 13, 2023Completed
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:July 15, 2015Completed
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:January 7, 2016Completed
Condition(s):Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)Last Updated:August 1, 2019Completed
Condition(s):HealthyLast Updated:October 9, 2014Completed
Condition(s):Cystic FibrosisLast Updated:June 24, 2014Completed
Condition(s):HealthyLast Updated:October 15, 2014Completed
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:September 17, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.